Frontiers in Cancer Immunotherapy

Frontiers in Cancer Immunotherapy

Thursday, April 26, 2018 - Friday, April 27, 2018

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

Cancer Discussion Group

The New York Academy of Sciences

 

The recent FDA approval of a gene therapy for leukemia treatment marks a new frontier in medical innovation for the field of cancer immunotherapy. This 2-day scientific symposium will explore cutting-edge findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches. Plenary speakers active in the fields of cancer biology, immunology, and cancer immunotherapy will present on an array of topics, including: new mechanistic perspectives from basic and preclinical research, results from early phase clinical trials of combination therapies, the durability of treatment responses to CAR-T cell therapies, and managing the known toxicity of effective immunotherapies in clinical trials.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is  February 23, 2018.

Registration

Member
By 03/09/2018
$175
After 03/09/2018
$200
Onsite
$250
Nonmember Academia, Faculty, etc.
By 03/09/2018
$250
After 03/09/2018
$300
Onsite
$375
Nonmember Corporate, Other
By 03/09/2018
$350
After 03/09/2018
$400
Onsite
$475
Nonmember Not for Profit
By 03/09/2018
$250
After 03/09/2018
$300
Onsite
$375
Nonmember Student, Undergrad, Grad, Fellow
By 03/09/2018
$175
After 03/09/2018
$200
Onsite
$350
Member Student, Post-Doc, Fellow
By 03/09/2018
$150
After 03/09/2018
$175
Onsite
$225

Organizers

Frontiers in Cancer Immunotherapy
George Zavoico, PhD, B. Riley FBR
Frontiers in Cancer Immunotherapy
Chris Boshoff, MD, PhD, Pfizer
Frontiers in Cancer Immunotherapy
Sridhar Ramaswamy, MD, Tesaro
Frontiers in Cancer Immunotherapy
Renier Brentjens, MD, PhD, Memorial Sloan Kettering Cancer Center
Frontiers in Cancer Immunotherapy
Sonya Dougal, PhD, The New York Academy of Sciences

Keynote Speakers

Frontiers in Cancer Immunotherapy
Miriam Merad, MD, PhD, Icahn School of Medicine at Mount Sinai
Frontiers in Cancer Immunotherapy
Jeffrey V. Ravetch, MD, PhD, The Rockefeller University

Speakers

Frontiers in Cancer Immunotherapy
Brian Ruffell, PhD, Moffitt Cancer Center
Frontiers in Cancer Immunotherapy
Dale L. Greiner PhD, University of Massachusetts Medical School
Frontiers in Cancer Immunotherapy
Marcela V. Maus, MD PhD, Harvard Medical School​
Frontiers in Cancer Immunotherapy
Marco Davila, MD, PhD, Moffitt Cancer Center
Frontiers in Cancer Immunotherapy
Prasad S. Adusumilli, MD, Memorial Sloan Kettering Cancer Center
Frontiers in Cancer Immunotherapy
Rong Fan, PhD, Yale University
Frontiers in Cancer Immunotherapy
Hans Klingemann, MD, PhD, NantKwest
Frontiers in Cancer Immunotherapy
Timothy Chan, MD, PhD, Memorial Sloan Kettering Cancer Center
Frontiers in Cancer Immunotherapy
David Spencer, PhD, Bellicum Pharmaceuticals
Frontiers in Cancer Immunotherapy
Noah Palm, PhD, Yale University School of Medicine
Frontiers in Cancer Immunotherapy
Paolo Fiorina, MD, PhD, Harvard Medical School
Frontiers in Cancer Immunotherapy
Hyam Levitsky, MD, Juno Therapeutics
Frontiers in Cancer Immunotherapy
Christopher Klebanoff, MD, Memorial Sloan Kettering Cancer Center
Frontiers in Cancer Immunotherapy
Sridhar Ramaswamy, MD, Tesaro
Frontiers in Cancer Immunotherapy
Jennifer Wargo, MD, MD Anderson Cancer Center
Frontiers in Cancer Immunotherapy
Maria Fardis, PhD, MBA, Iovance Biotherapeutics

Sponsors

The Cancer Discussion Group is Proudly Supported by:

Premiere Supporter

Silver Sponsor